Management of metabolic syndrome by nutraceuticals prepared from chitosan and ferulic acid with or without beta-sitosterol and their nanoforms

[1]  Z. Shan,et al.  Factors Related to Metabolic Syndrome Development and Recovery in Chinese Adults: A Prospective Longitudinal Study , 2022, Frontiers in Endocrinology.

[2]  T. Farooq,et al.  Priming with copper-chitosan nanoparticles elicit tolerance against PEG-induced hyperosmotic stress and salinity in wheat , 2022, BMC Chemistry.

[3]  S. Nasr,et al.  Kishk Sa′eedi as a potential functional food for management of metabolic syndrome: A study of the possible interaction with pomegranate seed oil and/ or gum Arabic , 2021, Journal of Herbmed Pharmacology.

[4]  Selvaraj Jayaraman,et al.  An update on β-sitosterol: A potential herbal nutraceutical for diabetic management. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  S. Al-Okbi,et al.  Role of Borage Seed Oil and Fish Oil with or without Turmeric and Alpha- Tocopherol in Prevention of Cardiovascular Disease and Fatty Liver in Rats. , 2018, Journal of oleo science.

[6]  S. Tuntipopipat,et al.  Ferulic Acid Supplementation Improves Lipid Profiles, Oxidative Stress, and Inflammatory Status in Hyperlipidemic Subjects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2018, Nutrients.

[7]  P. Strappe,et al.  Enhanced anti-obesity effects of complex of resistant starch and chitosan in high fat diet fed rats. , 2017, Carbohydrate polymers.

[8]  E. Moustafa,et al.  Beta-sitosterol upregulated paraoxonase-1 via peroxisome proliferator-activated receptor-γ in irradiated rats. , 2017, Canadian journal of physiology and pharmacology.

[9]  R. Sharmila,et al.  Nephroprotective effect of β-sitosterol on N-diethylnitrosamine initiated and ferric nitrilotriacetate promoted acute nephrotoxicity in Wistar rats , 2016, Journal of basic and clinical physiology and pharmacology.

[10]  J. Godos,et al.  Natural antioxidants for non‐alcoholic fatty liver disease: molecular targets and clinical perspectives , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[11]  Akilavalli Narasimhan,et al.  Ferulic acid regulates hepatic GLUT2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat. , 2015, European journal of pharmacology.

[12]  T. Xiao,et al.  Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats , 2015, Marine drugs.

[13]  M. Rinaudo,et al.  Chitin and Chitosan Preparation from Marine Sources. Structure, Properties and Applications , 2015, Marine drugs.

[14]  H. Majeed,et al.  Ferulic acid renders protection to HEK293 cells against oxidative damage and apoptosis induced by hydrogen peroxide , 2015, In Vitro Cellular & Developmental Biology - Animal.

[15]  T. Osaki,et al.  Anticancer and Anti-Inflammatory Properties of Chitin and Chitosan Oligosaccharides , 2015, Journal of functional biomaterials.

[16]  K. Im,et al.  Appraisal of Antioxidant and Anti-Inflammatory Activities of Various Extracts from the Fruiting Bodies of Pleurotus florida , 2014, Molecules.

[17]  V. Giusti,et al.  Exercise Prevents Fructose-Induced Hypertriglyceridemia in Healthy Young Subjects , 2013, Diabetes.

[18]  James M. Rippe,et al.  Sucrose, High-Fructose Corn Syrup, and Fructose, Their Metabolism and Potential Health Effects: What Do We Really Know?12 , 2013, Advances in nutrition.

[19]  V. Menon,et al.  Protective role of ferulic acid on carbon tetrachloride-induced hyperlipidemia and histological alterations in experimental rats , 2013, Journal of basic and clinical physiology and pharmacology.

[20]  K. Cusi,et al.  Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. , 2012, Gastroenterology.

[21]  F. Ahmad,et al.  Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  Rajnish A. Gupta,et al.  Antidiabetic and antioxidant potential of β‐sitosterol in streptozotocin‐induced experimental hyperglycemia , 2011, Journal of diabetes.

[23]  K. Adeli,et al.  Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. , 2010, American journal of physiology. Endocrinology and metabolism.

[24]  Fang Gao,et al.  The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. , 2010, International journal of pharmaceutics.

[25]  D. Noto,et al.  Obesity and the metabolic syndrome in a student cohort from Southern Italy. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[26]  P. Whincup,et al.  HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. , 2009, Atherosclerosis.

[27]  D. Topping,et al.  Soluble fiber polysaccharides: effects on plasma cholesterol and colonic fermentation. , 2009, Nutrition reviews.

[28]  Á. Ravelo,et al.  Dichloromethane as a solvent for lipid extraction and assessment of lipid classes and fatty acids from samples of different natures. , 2008, Journal of agricultural and food chemistry.

[29]  A. Trapani,et al.  Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan , 2008, Nanotechnology.

[30]  J. German,et al.  Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. , 2007, The American journal of clinical nutrition.

[31]  Leslie Z. Benet,et al.  PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISM , 2006, Drug Metabolism and Disposition.

[32]  A. Åsberg,et al.  Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several‐fold in patients with atorvastatin‐induced myopathy , 2006, Clinical pharmacology and therapeutics.

[33]  H. Shimoda,et al.  Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice , 2006, BMC complementary and alternative medicine.

[34]  N. Cook,et al.  Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. , 2005, JAMA.

[35]  F. Fazio,et al.  Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients. , 2004, American journal of physiology. Heart and circulatory physiology.

[36]  C. Pichot,et al.  Formation and properties of positively charged colloids based on polyelectrolyte complexes of biopolymers. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[37]  H. Bokura,et al.  Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial , 2003, European Journal of Clinical Nutrition.

[38]  R. Mensink,et al.  Effects on the human serum lipoprotein profile of beta-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. , 2002, The Journal of nutrition.

[39]  G. Koraćević,et al.  Method for the measurement of antioxidant activity in human fluids , 2001, Journal of clinical pathology.

[40]  Villar,et al.  Anti-inflammatory and immunomodulating properties of a sterol fraction from Sideritis foetens Clem. , 2001, Biological & pharmaceutical bulletin.

[41]  L-K Han,et al.  Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet , 1999, International Journal of Obesity.

[42]  L. Prencipe,et al.  Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. , 1982, Clinical chemistry.

[43]  S. Sakuta,et al.  Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. , 1978, Clinica chimica acta; international journal of clinical chemistry.

[44]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[45]  C. Heierli,et al.  [Serum creatinine determination without protein precipitation]. , 1972, Clinica chimica acta; international journal of clinical chemistry.

[46]  P. Trinder,et al.  Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen , 1969, Journal of clinical pathology.

[47]  J. E. Scott,et al.  A RAPID AND PRECISE METHOD FOR THE DETERMINATION OF UREA , 1960, Journal of clinical pathology.

[48]  S REITMAN,et al.  A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. , 1957, American journal of clinical pathology.

[49]  D. P. de Sousa,et al.  Ferulic acid ethyl ester diminished Complete Freund’s Adjuvant-induced incapacitation through antioxidant and anti-inflammatory activity , 2015, Naunyn-Schmiedeberg's Archives of Pharmacology.

[50]  Kyung-Chul Choi,et al.  Risk of cardiovascular disease is suppressed by dietary supplementation with protamine and chitooligosaccharide in Sprague-Dawley rats. , 2013, Molecular medicine reports.

[51]  Jiao Guo,et al.  Water-soluble chitosan nanoparticles inhibit hypercholesterolemia induced by feeding a high-fat diet in male sprague-dawley rats , 2011 .

[52]  S. Giammanco,et al.  Citrus Flavonoids: molecular structure, biological activity and nutritional properties: a review , 2007 .

[53]  H. Lennernäs.  Clinical Pharmacokinetics of Atorvastatin , 2003, Clinical pharmacokinetics.

[54]  Joseph L Evans,et al.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.

[55]  R. Rouseff,et al.  Distribution of bound and free phenolic acids in oranges (Citrus sinensis) and Grapefruits (Citrus paradisi) , 1991 .